At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SPRY ARS PHARMACEUTICALS INC
Closed Mourning Day 01-08 16:00:00 EST
11.43
+0.09
+0.79%
盘后11.70
+0.27+2.36%
18:29 EST
High11.60
Low10.86
Vol1.31M
Open11.16
D1 Closing11.34
Amplitude6.52%
Mkt Cap1.11B
Tradable Cap531.73M
Total Shares97.19M
T/O14.79M
T/O Rate2.81%
Tradable Shares46.52M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
ARS Pharmaceuticals files for approval of neffy in Canada, U.K.
ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis. The company was founded in 2015 and is based in San Diego, California.